Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,896 | -107,979 | -60,508 | -19,435 | -85,477 |
| Depreciation Amortization | 5,130 | 5,566 | 9,297 | 8,338 | 10,038 |
| Accounts receivable | -12,246 | 781 | 6,407 | -4,473 | -5,260 |
| Other Working Capital | -76,468 | -6,498 | -9,897 | 84,974 | 5,363 |
| Other Operating Activity | 45,004 | 10,017 | -46,697 | 3,396 | 31,289 |
| Operating Cash Flow | $-61,476 | $-98,113 | $-101,398 | $72,800 | $-44,047 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 140 | 1,113 | -8,858 | -9,104 | -1,746 |
| Sale Of Investment | N/A | N/A | 49,553 | 0 | 0 |
| Other Investing Activity | -890 | -9,264 | 209 | 439 | -425 |
| Investing Cash Flow | $-750 | $-8,151 | $40,904 | $-8,665 | $-2,171 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,979 | -2,492 | -2,057 | -1,664 | -1,313 |
| Common Stock Issued | 370 | 103,628 | 5,225 | 3,315 | 151,218 |
| Other Financing Activity | 320 | 0 | 0 | 0 | -5,799 |
| Financing Cash Flow | $-2,289 | $101,136 | $3,168 | $1,651 | $144,106 |
| Exchange Rate Effect | -294 | -1,897 | -1,343 | 1 | 571 |
| Beginning Cash Position | 156,384 | 163,209 | 221,878 | 156,091 | 57,632 |
| End Cash Position | 91,575 | 156,184 | 163,209 | 221,878 | 156,091 |
| Net Cash Flow | $-64,809 | $-7,025 | $-58,669 | $65,787 | $98,459 |
| Free Cash Flow | |||||
| Operating Cash Flow | -61,476 | -98,113 | -101,398 | 72,800 | -44,047 |
| Capital Expenditure | -814 | -1,119 | -8,905 | -9,164 | -1,777 |
| Free Cash Flow | -62,290 | -99,232 | -110,303 | 63,636 | -45,824 |